GlassScriptPhysician profile
Heather Y Young
NPI 1003480716
$3,863.89
in general payments reported to CMS, 2019-2025
16 companies · $1,445 in 2025
The $1,445 reported for 2025 was more than what 92% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $530 · 2024: $1,889 · 2025: $1,445.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,837 · Gift: $27.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,836.61 |
| Gift | $27.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $779.89 | 2023-2025 | |
| Janssen Biotech, INC. | $513.69 | 2023-2025 | Stelara, Tremfya |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $470.30 | 2023-2025 | Trulance, Xifaxan |
| Genzyme Corporation | $363.53 | 2023-2025 | |
| Madrigal Pharmaceuticals | $322.16 | 2024-2025 | Rezdiffra, Resmetirom |
| Phathom Pharmaceuticals, INC. | $245.13 | 2024-2025 | Voquezna |
| Aimmune Therapeutics, INC. | $215.48 | 2024-2025 | Vowst, Zenpep |
| Gilead Sciences, INC. | $174.58 | 2025 | Livdelzi |
| Lilly USA, LLC | $156.21 | 2023-2025 | Omvoh |
| Takeda Pharmaceuticals U.S.A., INC. | $136.77 | 2023-2025 | Entyvio, Gattex |
| Merck Sharp & Dohme LLC | $125.53 | 2023-2024 | Dificid |
| Braintree Laboratories, INC. | $115.71 | 2023-2025 | Suflave, Sutab |
| Qol Medical, LLC | $91.98 | 2024-2025 | Sucraid, Sucraid |
| Regeneron Healthcare Solutions, INC. | $73.14 | 2023-2025 | Dupixent |
| Fresenius Kabi USA, LLC | $64.98 | 2023-2024 | Idacio |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intercept Pharmaceuticals, INC. | $14.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heather Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.